Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus reuteri for functional constipation in children
IRCT20150706023084N13Phase 3Completed
- Sponsor
- Faradaro Fanavar Mehr
- Start
- Jan 2022
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of lactobacillus reuteri in functional constipation (FC), sponsored by Faradaro Fanavar Mehr. Started Jan 2022; status: completed.
02
Drugs
lactobacillus reuteri
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on IRCT20150706023084N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150706023084N13.